Research Reports Initiation on Specialized Health Services Stocks -- AMN Healthcare Services, Healthways, MEDNAX, and HEALTHSOUTH

Sep 19, 2016, 07:05 ET from Chelmsford Park SA

NEW YORK, September 19, 2016 /PRNewswire/ --

In today's pre-market research, has lined up four Specialized Health Services equities for assessment: AMN Healthcare Services Inc. (NYSE: AHS), Healthways Inc. (NASDAQ: HWAY), MEDNAX Inc. (NYSE: MD), and HEALTHSOUTH Corp. (NYSE: HLS). These companies belong to the Healthcare sector which finished narrowly mixed in afternoon trading on Friday, September 16, 2016. As per an article on the NASDAQ, the NYSE Health Care Index slid 0.1%, while shares of health care companies in the S&P 500 rose about 0.2% as a group. Learn more about these stocks by downloading their free report at:

AMN Healthcare Services  

San Diego, California headquartered AMN Healthcare Services Inc.'s stock finished Friday's session 0.09% higher at $34.74 with a total trading volume of 680,097 shares. The Company's shares have advanced 1.46% in the past month and 11.88% on an YTD basis. The stock is trading 1.57% above its 200-day moving average. Additionally, shares of AMN Healthcare Services, which provides healthcare workforce solutions and staffing services in the US, have a Relative Strength Index (RSI) of 38.54.

On August 4th, 2016, the company reported that consolidated revenue was $474 million for Q2 2016, up 35% from Q2 2015. Gross margin was 32.7%, which is 130 basis points higher than Q2 2015. The company's net income was $26 million, or $0.53 per diluted share. Excluding amortization of intangible assets and acquisition and integration costs, net of tax, adjusted net income per diluted share was $0.61. The free research report on AHS is available at:


Last Friday, shares in Tennessee headquartered Healthways Inc. recorded a trading volume of 572,865 shares. The stock ended the session 1.18% higher at $24.96. The Company's shares have advanced 3.48% in the last one month, 108.52% over the previous three months, and 93.94% since the start of this year. The stock is trading 28.39% above its 50-day moving average and 83.35% above its 200-day moving average. Moreover, shares of Healthways, which together with its subsidiaries, provides network delivered solutions and population health management services to help people to enhance well-being and health, have an RSI of 63.99.

On August 10th, 2016, Healthways announced that Robert E. Dries has been named executive vice president and chief financial officer, effective August 22nd, 2016. Dries will succeed Alfred Lumsdaine, who is expected to join Sharecare, Inc. in October 2016. Mr. Dries most recently served as senior vice president, financial operations of Omnicare, Inc., a subsidiary of CVS Health Corp.  

On August 22nd, 2016, research firm Barclays upgraded the Company's stock rating from 'Underweight' to 'Equal Weight'. The research firm also revised upwards its previous target price from $12 to $27. The complimentary report on HWAY can be downloaded at:


Shares in Florida-based MEDNAX Inc. closed the day 0.31% lower at $65.06. The stock recorded a trading volume of 1.02 million shares, which was higher than its three months average volume of 619,330 shares. The Company's shares have gained 1.28% in the last month and are trading 4.90% below their 200-day moving average. Additionally, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 41.03.

On September 16th, 2016, MEDNAX, announced the acquisitions of Medical Anesthesia Consultants, LLC, a private physician group practice based in Florence, S.C. and Anesthesia Associates of Naples, P.A., a private physician group practice based in Naples, Fla. These practices were acquired for cash and the transactions are expected to be immediately accretive to earnings. No additional terms of these transactions were disclosed. Visit us today and download our complete research report on MD for free at:


At the close, shares in Alabama headquartered HEALTHSOUTH Corp. ended the day at $40.54, rising 0.32%. The stock recorded a trading volume of 693,997 shares, which was above its three months average volume of 604,970 shares. The Company's shares have advanced 0.22% in the last one month, 2.87% in the previous three months, and 17.90% on an YTD basis. The stock is trading above its 200-day moving average by 8.07%. Furthermore, shares of HEALTHSOUTH, which owns and operates inpatient rehabilitation hospitals, home health agencies, and hospice agencies in the US, have an RSI of 48.07.

On August 29th, 2016, HealthSouth and Tidelands Health formed a joint venture to own and operate Tidelands' existing inpatient rehabilitation hospital located at 4070 Highway 17 Bypass South in Murrells Inlet, South Carolina, on the campus of Tidelands Waccamaw Community Hospital. The joint venture expects to operate 29 inpatient rehabilitation beds at this location. In addition, the joint venture plans to file a Certificate of Need application to build a second, 46-bed inpatient rehabilitation hospital that will be located in Little River, South Carolina. Get free access to your technical report on HLS at:


Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA